• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $SI

    Shoulder Innovations Inc.

    Subscribe to $SI
    $SI
    Medical/Dental Instruments
    Health Care

    Silvergate Capital Corporation operates as a bank holding company for Silvergate Bank that provides banking products and services to business and individual clients in the United States and internationally. The company accepts deposit products, including interest and noninterest bearing demand accounts, money market and savings accounts, and certificates of deposit accounts. Its loan products comprise one-to-four family real estate loans, multi-family real estate loans, commercial real estate loans, construction loans, commercial and industrial loans, mortgage warehouse loans, and reverse mortgage loans, as well as consumer loans and other loans secured by personal property. The company also provides cash management services for digital currency-related businesses. The company was founded in 1988 and is headquartered in La Jolla, California.

    IPO Year: 2025

    Exchange: NYSE

    Website: silvergate.com

    Peers

    $PVBC

    Recent Analyst Ratings for Shoulder Innovations Inc.

    DatePrice TargetRatingAnalyst
    3/6/2023Neutral → Sell
    Compass Point
    3/6/2023$9.00 → $4.00Neutral → Underperform
    Wedbush
    3/2/2023$16.00 → $10.00Buy → Neutral
    Compass Point
    3/2/2023Neutral → Underweight
    JP Morgan
    3/2/2023$25.00 → $9.00Buy → Hold
    Canaccord Genuity
    3/1/2023$25.00 → $16.00Outperform → Mkt Perform
    Keefe Bruyette
    1/9/2023$15.00 → $9.00Outperform → Neutral
    Wedbush
    1/6/2023$36.00 → $14.00Buy → Hold
    Craig Hallum
    1/6/2023$37.00 → $8.00Neutral → Underperform
    BofA Securities
    1/6/2023$30.00 → $14.00Overweight → Neutral
    JP Morgan
    See more ratings

    Shoulder Innovations Inc. SEC Filings

    View All

    SEC Form SCHEDULE 13D filed by Shoulder Innovations Inc.

    SCHEDULE 13D - SHOULDER INNOVATIONS, INC. (0001699350) (Subject)

    8/5/25 6:49:13 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    SEC Form 8-K filed by Shoulder Innovations Inc.

    8-K - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)

    8/4/25 4:09:43 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    SEC Form S-8 filed by Shoulder Innovations Inc.

    S-8 - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)

    8/1/25 4:05:59 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    SEC Form 424B4 filed by Shoulder Innovations Inc.

    424B4 - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)

    7/31/25 9:30:28 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    SEC Form EFFECT filed by Silvergate Capital Corporation

    EFFECT - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)

    7/31/25 12:15:24 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    SEC Form FWP filed by Silvergate Capital Corporation

    FWP - SHOULDER INNOVATIONS, INC. (0001699350) (Subject)

    7/30/25 9:15:40 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    SEC Form CERT filed by Silvergate Capital Corporation

    CERT - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)

    7/30/25 11:31:07 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    SEC Form 8-A12B filed by Silvergate Capital Corporation

    8-A12B - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)

    7/30/25 11:00:13 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form S-1/A filed by Silvergate Capital Corporation

    S-1/A - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)

    7/25/25 12:29:37 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form S-1/A filed by Silvergate Capital Corporation

    S-1/A - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)

    7/24/25 7:00:43 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Shoulder Innovations Inc. Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Gilde Healthcare Holding B.V. converted options into 2,280,482 shares and bought $1,500,000 worth of shares (100,000 units at $15.00) (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    8/5/25 6:37:22 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Director Buchholz Richard was granted 7,666 shares and bought $75,000 worth of shares (5,000 units at $15.00) (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    8/5/25 4:05:17 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Director Pardo Geoffrey B converted options into 2,280,482 shares, bought $1,500,000 worth of shares (100,000 units at $15.00) and was granted 7,666 shares (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    8/5/25 4:05:11 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Director Tansey Casey M converted options into 2,693,121 shares, was granted 7,666 shares and bought $600,000 worth of shares (40,000 units at $15.00) (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    8/5/25 4:05:09 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Former 10% Owner Lsv Associates Ii, Llc converted options into 1,618,470 shares and bought $3,999,990 worth of shares (266,666 units at $15.00) (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    8/5/25 4:05:15 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Director Carusi Michael A converted options into 1,618,470 shares, bought $3,999,990 worth of shares (266,666 units at $15.00) and was granted 7,666 shares (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    8/5/25 4:05:19 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    CHIEF FINANCIAL OFFICER Points Jeffrey S. bought $750 worth of shares (50 units at $15.00) (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    8/5/25 4:05:08 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Shoulder Innovations Inc. Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Silvergate Capital downgraded by Compass Point

    Compass Point downgraded Silvergate Capital from Neutral to Sell

    3/6/23 9:15:32 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Silvergate Capital downgraded by Wedbush with a new price target

    Wedbush downgraded Silvergate Capital from Neutral to Underperform and set a new price target of $4.00 from $9.00 previously

    3/6/23 7:35:32 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Silvergate Capital downgraded by Compass Point with a new price target

    Compass Point downgraded Silvergate Capital from Buy to Neutral and set a new price target of $10.00 from $16.00 previously

    3/2/23 9:50:56 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Silvergate Capital downgraded by JP Morgan

    JP Morgan downgraded Silvergate Capital from Neutral to Underweight

    3/2/23 6:38:29 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Silvergate Capital downgraded by Canaccord Genuity with a new price target

    Canaccord Genuity downgraded Silvergate Capital from Buy to Hold and set a new price target of $9.00 from $25.00 previously

    3/2/23 6:37:52 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Silvergate Capital downgraded by Keefe Bruyette with a new price target

    Keefe Bruyette downgraded Silvergate Capital from Outperform to Mkt Perform and set a new price target of $16.00 from $25.00 previously

    3/1/23 6:48:20 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Silvergate Capital downgraded by Wedbush with a new price target

    Wedbush downgraded Silvergate Capital from Outperform to Neutral and set a new price target of $9.00 from $15.00 previously

    1/9/23 9:11:03 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Silvergate Capital downgraded by Craig Hallum with a new price target

    Craig Hallum downgraded Silvergate Capital from Buy to Hold and set a new price target of $14.00 from $36.00 previously

    1/6/23 8:59:28 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Silvergate Capital downgraded by BofA Securities with a new price target

    BofA Securities downgraded Silvergate Capital from Neutral to Underperform and set a new price target of $8.00 from $37.00 previously

    1/6/23 8:58:38 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Silvergate Capital downgraded by JP Morgan with a new price target

    JP Morgan downgraded Silvergate Capital from Overweight to Neutral and set a new price target of $14.00 from $30.00 previously

    1/6/23 8:02:37 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Shoulder Innovations Inc. Financials

    Live finance-specific insights

    View All

    Silvergate Suspends Series A Preferred Stock Dividend

    Silvergate Capital Corporation (the "Company" or "Silvergate") (NYSE:SI), the leading provider of innovative financial infrastructure solutions to the digital asset industry, today announced that the Company has suspended the payment of dividends on its 5.375% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series A, in order to preserve capital. This decision reflects the Company's focus on maintaining a highly liquid balance sheet with a strong capital position as it navigates recent volatility in the digital asset industry. The Company continues to maintain a cash position in excess of its digital asset customer related deposits. The Company's Board of Directors will re-evaluate th

    1/27/23 6:55:00 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Silvergate Capital Corporation Announces Fourth Quarter 2022 Results

    Silvergate Capital Corporation ("Silvergate" or "Company") (NYSE:SI) and its wholly-owned subsidiary, Silvergate Bank ("Bank"), today announced financial results for the three and twelve months ended December 31, 2022. Fourth Quarter 2022 Commentary During the fourth quarter of 2022, the digital asset industry experienced a transformational shift, with significant over-leverage in the industry leading to several high-profile bankruptcies. These dynamics created a crisis of confidence across the ecosystem and led many industry participants to shift to a "risk off" position across digital asset trading platforms. In turn, the Company saw significant outflows of deposits during the quarter a

    1/17/23 6:25:00 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Silvergate Announces Select Preliminary Fourth Quarter 2022 Financial Metrics and Provides Business Update

    Company to Host Conference Call Today at 8:00 a.m. ET to Discuss Recent Developments Silvergate Capital Corporation ("Silvergate" or the "Company") (NYSE:SI), the leading provider of innovative financial infrastructure solutions to the digital asset industry, today announced select unaudited and preliminary financial metrics for the three months ended December 31, 2022 and provided a business update. These metrics are subject to change in connection with conducting and completing normal closing procedures and an audit for the year ended December 31, 2022. The Company will also host a conference call at 8:00 a.m. (Eastern Time) today, January 5, 2023, to discuss certain recent developments.

    1/5/23 6:45:00 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Silvergate To Provide Select Preliminary Fourth Quarter 2022 Financial Metrics and Host Business Update Conference Call

    Silvergate Capital Corporation ("Silvergate" or the "Company") (NYSE:SI), the leading provider of innovative financial infrastructure solutions to the digital asset industry, today announced that it will release select unaudited and preliminary fourth quarter 2022 financial metrics before market open on Thursday, January 5, 2023, with a conference call to follow at 8:00 a.m. (Eastern Time). The conference call can be accessed live by dialing 1-844-200-6205, or for international callers 1-929-526-1599, and entering the access code 712040. A replay will be available starting at 10:00 a.m. (Eastern Time) on January 5, 2023 and can be accessed by dialing 1-866-813-9403, or for international ca

    1/4/23 4:30:00 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Silvergate Capital Corporation Announces Third Quarter 2022 Results

    Silvergate Capital Corporation ("Silvergate" or "Company") (NYSE:SI) and its wholly-owned subsidiary, Silvergate Bank ("Bank"), today announced financial results for the three and nine months ended September 30, 2022. Third Quarter 2022 Highlights Net income for the quarter was $43.3 million, compared to $38.6 million for the second quarter of 2022, and $23.5 million for the third quarter of 2021 Net income available to common shareholders for the quarter was $40.6 million, or $1.28 per diluted common share, compared to net income of $35.9 million, or $1.13 per diluted share, for the second quarter of 2022, and net income of $23.5 million, or $0.88 per diluted share, for the third qua

    10/18/22 6:25:00 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Silvergate Capital Corporation Announces Third Quarter 2022 Financial Results Release Date and Conference Call

    Silvergate Capital Corporation (the "Company" or "Silvergate") (NYSE:SI), the leading provider of innovative financial infrastructure solutions to the digital asset industry, today announced that it will release its third quarter 2022 financial results before market open on Tuesday, October 18, 2022, with a conference call to follow at 11:00 a.m. (Eastern Time) the same day. The conference call can be accessed live by dialing 1-844-200-6205, or for international callers 1-929-526-1599, and entering the access code 636898. A replay will be available starting at 1:00 p.m. (Eastern Time) on October 18, 2022 and can be accessed by dialing 1-866-813-9403, or for international callers +44-204-52

    10/4/22 9:00:00 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Silvergate Capital Corporation Announces Second Quarter 2022 Results

    Silvergate Capital Corporation ("Silvergate" or "Company") (NYSE:SI) and its wholly-owned subsidiary, Silvergate Bank ("Bank"), today announced financial results for the three and six months ended June 30, 2022. Second Quarter 2022 Highlights Net income for the quarter was $38.6 million, compared to $27.4 million for the first quarter of 2022, and $20.9 million for the second quarter of 2021 Net income available to common shareholders for the quarter was $35.9 million, or $1.13 per diluted common share, compared to net income of $24.7 million, or $0.79 per diluted share, for the first quarter of 2022, and net income of $20.9 million, or $0.80 per diluted share, for the second quarter o

    7/19/22 6:25:00 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Silvergate Capital Corporation Announces Second Quarter 2022 Financial Results Release Date and Conference Call

    Silvergate Capital Corporation (the "Company" or "Silvergate") (NYSE:SI), the leading provider of innovative financial infrastructure solutions to the digital currency industry, today announced that it will release its second quarter 2022 financial results before market open on Tuesday, July 19, 2022, with a conference call to follow at 11:00 a.m. (Eastern Time) the same day. The conference call can be accessed live by dialing 1-844-200-6205, or for international callers 1-929-526-1599, and entering the access code 200185. A replay will be available starting at 1:00 p.m. (Eastern Time) on July 19, 2022 and can be accessed by dialing 1-866-813-9403, or for international callers +44-204-525-

    7/5/22 9:00:00 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Silvergate Capital Corporation Announces First Quarter 2022 Results

    Silvergate Capital Corporation ("Silvergate" or "Company") (NYSE:SI) and its wholly-owned subsidiary, Silvergate Bank ("Bank"), today announced financial results for the three months ended March 31, 2022. First Quarter 2022 Highlights Net income for the quarter was $27.4 million, compared to $21.4 million for the fourth quarter of 2021, and $12.7 million for the first quarter of 2021 Net income available to common shareholders for the quarter was $24.7 million, or $0.79 per diluted common share, compared to net income of $18.4 million, or $0.66 per diluted share, for the fourth quarter of 2021, and net income of $12.7 million, or $0.55 per diluted share, for the first quarter of 2021

    4/19/22 6:25:00 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Silvergate Capital Corporation Announces First Quarter 2022 Financial Results Release Date and Conference Call

    Silvergate Capital Corporation (the "Company" or "Silvergate") (NYSE:SI), the leading provider of innovative financial infrastructure solutions to the digital currency industry, today announced that it will release its first quarter 2022 financial results before market open on Tuesday, April 19, 2022, with a conference call to follow at 11:00 a.m. (Eastern Time) the same day. The conference call can be accessed live by dialing 1-844-200-6205, or for international callers 1-929-526-1599, and entering the access code 487806. A replay will be available starting at 1:00 p.m. (Eastern Time) on April 19, 2022 and can be accessed by dialing 1-866-813-9403, or for international callers +44-204-525

    4/5/22 9:00:00 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Shoulder Innovations Inc. Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Silvergate Capital Corporation (Amendment)

    SC 13G/A - Silvergate Capital Corp (0001312109) (Subject)

    2/12/24 12:17:13 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Silvergate Capital Corporation (Amendment)

    SC 13G/A - Silvergate Capital Corp (0001312109) (Subject)

    5/22/23 4:03:17 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Silvergate Capital Corporation

    SC 13G - Silvergate Capital Corp (0001312109) (Subject)

    2/14/23 4:49:34 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Silvergate Capital Corporation

    SC 13G - Silvergate Capital Corp (0001312109) (Subject)

    2/14/23 10:47:38 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Silvergate Capital Corporation

    SC 13G - Silvergate Capital Corp (0001312109) (Subject)

    2/14/23 9:05:49 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Silvergate Capital Corporation

    SC 13G - Silvergate Capital Corp (0001312109) (Subject)

    2/13/23 4:14:59 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Silvergate Capital Corporation (Amendment)

    SC 13G/A - Silvergate Capital Corp (0001312109) (Subject)

    2/10/23 4:05:47 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Silvergate Capital Corporation (Amendment)

    SC 13G/A - Silvergate Capital Corp (0001312109) (Subject)

    2/10/23 4:04:59 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Silvergate Capital Corporation

    SC 13G - Silvergate Capital Corp (0001312109) (Subject)

    2/2/23 12:51:10 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Silvergate Capital Corporation

    SC 13G - Silvergate Capital Corp (0001312109) (Subject)

    1/13/23 4:35:43 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Shoulder Innovations Inc. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Gilde Healthcare Holding B.V. converted options into 2,280,482 shares and bought $1,500,000 worth of shares (100,000 units at $15.00) (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    8/5/25 6:37:22 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Director Buckman Paul converted options into 6,198 shares and was granted 7,666 shares (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    8/5/25 4:05:10 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Director Buchholz Richard was granted 7,666 shares and bought $75,000 worth of shares (5,000 units at $15.00) (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    8/5/25 4:05:17 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    CHIEF OPERATING OFFICER Ahearn Matthew Fraser converted options into 67,242 shares, increasing direct ownership by 165% to 108,035 units (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    8/5/25 4:05:10 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Director Pardo Geoffrey B converted options into 2,280,482 shares, bought $1,500,000 worth of shares (100,000 units at $15.00) and was granted 7,666 shares (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    8/5/25 4:05:11 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Director Tansey Casey M converted options into 2,693,121 shares, was granted 7,666 shares and bought $600,000 worth of shares (40,000 units at $15.00) (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    8/5/25 4:05:09 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    CEO & EXECUTIVE CHAIRMAN Ball Robert Joseph converted options into 85,888 shares, increasing direct ownership by 494% to 103,259 units (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    8/5/25 4:05:18 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Director Sidow Kevin K. was granted 7,666 shares and converted options into 12,344 shares (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    8/5/25 4:05:12 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Former 10% Owner Lsv Associates Ii, Llc converted options into 1,618,470 shares and bought $3,999,990 worth of shares (266,666 units at $15.00) (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    8/5/25 4:05:15 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Director Carusi Michael A converted options into 1,618,470 shares, bought $3,999,990 worth of shares (266,666 units at $15.00) and was granted 7,666 shares (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    8/5/25 4:05:19 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Shoulder Innovations Inc. Press Releases

    Fastest customizable press release news feed in the world

    View All

    NYSE Content Advisory: Pre-market update + Figma valued at over $19 billion in IPO

    NEW YORK, July 31, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Kristen Scholer delivers the pre-market update on July 31st Equities are catching a bid early Thursday after decent earnings reports from tech giants Microsoft and Meta. Apple and Amazon report their earnings after today's market close.Figma, which provides browser-based design software, raised $1.2 billion after pricing nearly 37 million shares at $33 each. The price was above an upwardly revised range and valued Figma at more than $19

    7/31/25 8:55:00 AM ET
    $ICE
    $SI
    Investment Bankers/Brokers/Service
    Finance
    Medical/Dental Instruments
    Health Care

    Silvergate Capital Corporation Receives Non-Compliance Notice from NYSE Regarding 10-K Filing

    Silvergate Capital Corporation ("Silvergate" or "Company") (NYSE:SI), the holding company for Silvergate Bank ("Bank"), today announced that on March 17, 2023 it received a letter from the New York Stock Exchange (the "NYSE") notifying the Company that it is not in compliance with the NYSE's continued listing standards given the Company failed to timely file its Annual Report on Form 10-K for the year ended December 31, 2022. Although Company management has been working diligently to complete required information for the Form 10-K, and a substantial part of such information has been completed, the Company needs additional time to complete tasks related to its Form 10-K and its independent r

    3/20/23 4:30:00 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Silvergate Capital Corporation Announces Intent to Wind Down Operations and Voluntarily Liquidate Silvergate Bank

    Company Considering How to Best Preserve Residual Value of its Assets Silvergate Capital Corporation ("Silvergate" or "Company") (NYSE:SI), the holding company for Silvergate Bank ("Bank"), today announced its intent to wind down operations and voluntarily liquidate the Bank in an orderly manner and in accordance with applicable regulatory processes. In light of recent industry and regulatory developments, Silvergate believes that an orderly wind down of Bank operations and a voluntary liquidation of the Bank is the best path forward. The Bank's wind down and liquidation plan includes full repayment of all deposits. The Company is also considering how best to resolve claims and preserve t

    3/8/23 4:30:00 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Silvergate Suspends Series A Preferred Stock Dividend

    Silvergate Capital Corporation (the "Company" or "Silvergate") (NYSE:SI), the leading provider of innovative financial infrastructure solutions to the digital asset industry, today announced that the Company has suspended the payment of dividends on its 5.375% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series A, in order to preserve capital. This decision reflects the Company's focus on maintaining a highly liquid balance sheet with a strong capital position as it navigates recent volatility in the digital asset industry. The Company continues to maintain a cash position in excess of its digital asset customer related deposits. The Company's Board of Directors will re-evaluate th

    1/27/23 6:55:00 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Silvergate Capital Corporation Investors: Please contact the Portnoy Law Firm to recover your losses; February 6, 2023 deadline

    Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Jan. 26, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Silvergate Capital Corporation ("Silvergate" or "the Company") (NYSE:SI) investors that a lawsuit filed on behalf of investors that purchased securities between November 9, 2021 and November 17, 2022. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to recov

    1/26/23 6:14:30 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Silvergate Provides Statement on Limited Exposure to Genesis

    Silvergate Capital Corporation (the "Company" or "Silvergate") (NYSE:SI), the leading provider of innovative financial infrastructure solutions to the digital asset industry, today announced a business update in connection with the recently announced bankruptcy filing by Genesis Global Holdco, LLC and its subsidiaries Genesis Global Capital LLC and Genesis Asia Pacific PTE LTD (collectively, "Genesis"). Silvergate's deposit relationship with Genesis was less than $2.5 million as of both December 31, 2022 and January 19, 2023. Genesis is not a custodian for Silvergate's bitcoin-collateralized SEN Leverage loans and Silvergate has no outstanding loans to nor investments in Genesis. While th

    1/20/23 4:30:00 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Silvergate Capital Corporation Announces Fourth Quarter 2022 Results

    Silvergate Capital Corporation ("Silvergate" or "Company") (NYSE:SI) and its wholly-owned subsidiary, Silvergate Bank ("Bank"), today announced financial results for the three and twelve months ended December 31, 2022. Fourth Quarter 2022 Commentary During the fourth quarter of 2022, the digital asset industry experienced a transformational shift, with significant over-leverage in the industry leading to several high-profile bankruptcies. These dynamics created a crisis of confidence across the ecosystem and led many industry participants to shift to a "risk off" position across digital asset trading platforms. In turn, the Company saw significant outflows of deposits during the quarter a

    1/17/23 6:25:00 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Silvergate Capital Corporation: Please contact the Portnoy Law Firm to recover your losses; January 13, 2023 deadline

    Investors can contact the law firm at no cost to learn more about recovering their losses ​LOS ANGELES, Jan. 12, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Silvergate Capital Corporation ("Silvergate") (NYSE:SI) investors that a lawsuit filed on behalf of investors that purchased Silvergate Capital Corporation (NYSE:SI) between November 9, 2021 and January 5, 2023, both dates inclusive. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' op

    1/12/23 6:24:17 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Grabar Law Office Investigates Claims on Behalf of Shareholders of Silvergate Capital Corporation (SI)

    Philadelphia, Pennsylvania--(Newsfile Corp. - January 12, 2023) - It is alleged that Silvergate Capital Corporation (NYSE:SI) and its officers failed to disclose that Silvergate's platform lacked basic controls to detect money laundering and that as a result certain Silvergate customers were able to engage in money laundering in amounts exceeding $425 million, exposing Silvergate to regulatory scrutiny and damages.Current Silvergate shareholders who have continuously held shares since at least November 9, 2021, can seek corporate reforms, the return of funds spent defending litigation back to the company, and a court approved incentive award, at no cost to them. If you would like to learn mo

    1/12/23 8:22:58 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Grabar Law Office Investigates Claims on Behalf of Shareholders of Silvergate Capital Corporation (SI)

    Philadelphia, Pennsylvania--(Newsfile Corp. - January 6, 2023) - According to a recently filed shareholder complaint, Silvergate Capital Corporation (NYSE:SI), a digital currency company, and certain of its officers, made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, it is alleged that the Company and its officers failed to disclose that the Company's platform lacked sufficient controls and procedures to detect instances of money laundering such that Silvergate's customers had engaged in money laundering in amounts exceeding $425 million and, as a result, Silvergate wa

    1/6/23 5:23:00 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Shoulder Innovations Inc. Leadership Updates

    Live Leadership Updates

    View All

    Silvergate announces changes to its executive team

    Silvergate Capital Corporation (the "Company" or "Silvergate") (NYSE:SI), the leading provider of innovative financial infrastructure solutions to the digital asset industry, today announced the promotion of Ben Reynolds to President, and appointment of Kate Fraher as Chief Risk Officer, of both the Company and its subsidiary, Silvergate Bank. In their new roles, Ben and Kate will continue reporting to Alan Lane, CEO of Silvergate and the bank. "We are excited about these new roles, which will benefit Silvergate as we continue to grow and mature as an organization," said Alan Lane, CEO of Silvergate. "Serving the digital asset industry requires that we continue to innovate and deliver prod

    11/7/22 4:30:00 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Silvergate Announces Appointment of Mary-Margaret Henke to Board of Directors

    Silvergate Capital Corporation (the "Company" or "Silvergate") (NYSE:SI), the leading provider of innovative financial infrastructure solutions to the digital currency industry, today announced the appointment of Mary-Margaret Henke to the board of directors of both the Company and its subsidiary bank, Silvergate Bank. "I am fortunate to be joining Silvergate's board during this period of continued evolution for both the bank and the digital assets industry," said Mary-Margaret Henke. "I look forward to working in tandem with my fellow Board members and management to ensure the Company remains a leader in innovative banking solutions." "Mary-Margaret's extensive knowledge of the financial

    9/19/22 4:15:00 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Silvergate Announces Appointment of Rebecca Rettig to Board of Directors

    Silvergate Capital Corporation (the "Company" or "Silvergate") (NYSE:SI), the leading provider of innovative financial infrastructure solutions to the digital currency industry, today announced the appointment of Rebecca Rettig to the board of directors for both the Company and its subsidiary bank, Silvergate Bank. "I am honored to join Silvergate's board at this moment of evolution in the bank's history and the digital asset ecosystem," said Rebecca Rettig. "I look forward to working with Silvergate's leadership and my fellow board members to strengthen the Company's leadership position in this evolving and innovative industry." "Rebecca's broad wealth of knowledge in the blockchain and

    3/16/22 9:00:00 AM ET
    $SI
    Medical/Dental Instruments
    Health Care